Metraipolis › archive › dc_783225aca899

Subcutaneous Abatacept in New Onset Type 1 Diabetes: Clinical and Immunological Effects — Europe PMC PMID:40790833

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40790833
DOI
10.1002/dmrr.70074
License (as archived)
solo-consultazione
Archived
2026-11-10T04:36:44.313Z
SHA-256 of the archived text
18e04b2e023f34c481a5790522f38c179fa49cb23dd1ceeaca28542f163e5f0e
Stable URL of this page
https://metraipolis.com/documento/dc_783225aca899

How to cite

Subcutaneous Abatacept in New Onset Type 1 Diabetes: Clinical and Immunological Effects — Europe PMC PMID:40790833 — Europe PMC (en), https://europepmc.org/article/MED/40790833 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_783225aca899 (Metraipolis archive dc_783225aca899, sha256 18e04b2e023f34c481a5790522f38c179fa49cb23dd1ceeaca28542f163e5f0e)
BibTeX
@misc{dc783225aca899,
  title = {Subcutaneous Abatacept in New Onset Type 1 Diabetes: Clinical and Immunological Effects — Europe PMC PMID:40790833},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40790833},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_783225aca899; sha256 18e04b2e023f34c481a5790522f38c179fa49cb23dd1ceeaca28542f163e5f0e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40790833. Agents can read the archived copy with the MCP tool read_document.